Concepedia

Alex R. Shoemaker

AR

Statistics

Publications

16

Citations

1.2K

H-Index

16

Active since

1994

Affiliations

University of Wisconsin–Madison(Current)

Abbott Fund

Abbott (United States)

AbbVie (United States)

Alex R. Shoemaker is an author at University of Wisconsin–Madison specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1994–2022

16

Publications

16

Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models

Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes et al. · Clinical Cancer Research · 2008 · 209 citations

Homozygosity for the <i>Min</i>allele of <i>Apc</i> results in disruption of mouse development prior to gastrulation

Amy Moser, Alex R. Shoemaker, Camille S. Connelly et al. · Developmental Dynamics · 1995 · 157 citations · Full text

A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs <i>In vitro</i> and <i>In vivo</i>

Alex R. Shoemaker, Anatol Oleksijew, Joy Bauch et al. · Cancer Research · 2006 · 146 citations

The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity

Kenneth D. Bromberg, Taylor R. H. Mitchell, Anup K. Upadhyay et al. · Nature Chemical Biology · 2017 · 127 citations · Full text

, , +10

N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts.

Alex R. Shoemaker, Amy Moser, William F. Dove · PubMed · 1995 · 76 citations

, , +15

1–5 of 16